Semaglutide Circus: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists to Treat Addiction Register Non-Member - $39 Regular Member - $29 Retired - $29 Early Career Physician - $29 Resident - $19 Student - $19 Associate - $19 ASAM Staff - Free
So then I was like, OK, I have to try something different." "That's kind of what led to this whole journey
Ren, L., Ma, Y., Xie, M., Lu, Y
adults currently take a GLP-1 for weight loss (up from 3 percent in 2024 and 8 percent in 2025) 15 percent have used a GLP-1 medication for weight loss at some point 68 percent of current users take brand-name medications such as Ozempic, Wegovy, or Zepbound 19 percent take compounded or custom-mixed GLP-1 versions not approved by the FDA 91 percent of Americans now know GLP-1 drugs can be used for weight loss (up from 80 percent in 2024) The Medicare GLP-1 Bridge, administered by the Centers for Medicare and Medicaid Services (CMS), is a demonstration program operating outside the standard Part D benefit
Epitalon (Epithalon, CAS 307297-39-8) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly, originally identified as the putative active component of bovine pineal gland extract epithalamin
Research shows it can increase vascularization by 129 to 152 percent in injured tissues
